George Cardoza, Chief Financial Officer at SOPHiA GENETICS SA (SOPH), sold 4,933 shares at $4.85 ($24K) on 2026-04-06, disclosed to the SEC on 2026-04-08.
Scheduled sale ($24k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.85 | 2,520 | $12K | 50.9% |
| 2 | $4.88 | 2,413 | $12K | 49.1% |
| Total | $4.86 avg | 4,933 | $24K | 100% |
| Filing → |
| SOPH | BUY | 2026-06-05 | $99K | — | Filing → |
| SOPH | SELL | 2026-04-10 | $7K | — | Filing → |
| SOPH | SELL | 2026-03-20 | $7K | — | Filing → |